Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Introduction:
Obesity is the most common chronic disease today and methods
for the prevention and treatment of obesity are an important area
of modern medicine. Among the new directions it is proposed
to use agonists of �²3-Adrenergic Receptors (�²3-AR), including
mirabegron. The purpose of this study was to confirm the ability
of mirabegron as a selective agonist of �²3-AR (compared to
ascorbic acid and adrenaline) to reduce the free radical activity
of erythrocytes, which are known to lack mitochondria (the main
sources of ROS), but are rich in lipids.
Materials and Methods:
The object of the study was heparinized venous blood of 20
male donors. The intensity of free radical activity was assessed
by the iron-induced biochemiluminescence method on a
biochemiluminometer BHL-07 manufactured by Medozons
(Russia). We studied the background values of blood
biochemiluminescence intensity (light sum S), which served as a
control and evaluated the effect of the agonist �²3-AR mirabegron,
ascorbic acid as a classic antioxidant and adrenaline.
Results:
It has been established (Table 1) that mirabegron at a concentration
of 10�6 g/mL of Krebs solution statistically significantly reduces
the intensity of erythrocyte biochemiluminescence. A similar
effect is exerted by the Classic antioxidant ascorbic acid (10�4 g/
mL), as well as adrenaline (10�5 g/mL).
Table 1. Indicators S of free radical activity of whole blood of male
donors under the action of ascorbic acid, adrenaline, mirabegron,
in % of the background level.
Adden dum
10-9 10-8 10-7 10-6 10-5 10-4
Whole blood
86A 92 88M 96 80*
Vitamin C - (83;92) (89;97) (80;97) (26;101) (70;87)
95 108AA 101 101 94
Adrenalin (86;107) (102;113) (93;116) (88;111) (85;96) -
90*AA
Mirabegron (84;94) - -
Conclusion:
This indicates the possibility and expediency of using mirabegron
for the treatment of obesity in which the intensity of lipid
peroxidation is increased.
Biography
Zavalin NS is a lecturer at the Department of Physics and Medical Informatics at the Kirov State Medical University. He graduated from the Vyatka state university of Humanities in 2015, Specialty is medical physics. Then he completed his postgraduate studies at the Vyatka State University in the direction of human physiology in 2019.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals